The management of side‐effects during therapy for hepatitis C
- 21 October 2004
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (9) , 917-929
Abstract
Summary: The results of interferon and ribavirin combination therapy for chronic hepatitis C infection have substantially improved in recent years, such that the majority of patients in randomized‐controlled trials now achieve a sustained virological response. However, adverse effects are commonplace, often disabling and may lead to interruption or cessation of therapy with subsequent loss of efficacy. Constitutional, neuropsychiatric and haematological reactions have proved particularly troublesome. In this review, we discuss these adverse effects in more detail and highlight recent advances in their management.Keywords
This publication has 50 references indexed in Scilit:
- 479 Moved to parallel session 7 safety and efficacy of viramidine in combination with pegylated interferon alfa-2A for treatment of hepatitis C in therapy-naïve patientsJournal of Hepatology, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Ribavirin-Induced Pure Red-Cell Aplasia during Treatment of Chronic Hepatitis CNew England Journal of Medicine, 2004
- Psychopharmacological Treatment of Depression, Anxiety, Irritability and Insomnia in Patients Receiving Interferon-α: a Prospective Case Series and a Discussion of Biological MechanismsJournal of Psychopharmacology, 2004
- The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patientsJournal of Hepatology, 2004
- Effect of Treatment With Peginterferon or Interferon Alfa–2B and Ribavirin on Steatosis in Patients Infected With Hepatitis CHepatology, 2003
- Activation and Deactivation of a Broad-Spectrum Antiviral Drug by a Single Enzyme: Adenosine Deaminase Catalyzes Two Consecutive Deamination ReactionsAntimicrobial Agents and Chemotherapy, 2003
- 1227 Delayed recovery of pegylated interferon and ribavirin induced anemiaHepatology, 2003
- Paroxetine for the Prevention of Depression Induced by High-Dose Interferon AlfaNew England Journal of Medicine, 2001
- Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosisHepatology, 1998